Application

18011878 · Anti-PD-1 Antibodies and Fusion Proteins

Filed 2022-12-21 · Abandoned The official file ↗ · Art unit 1643 · Examiner Bryan William Heck Typical · CPC C07K 16/2818 · Kadmon Corporation, LLC · Sanofi/McNeill PLLC

Office actions

first was Non-final rejection

RCEs

no appeal

To first action

31.0 mo

to disposition 33.8 mo

Statutes raised

112 DP

1 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.